Literature DB >> 6086760

Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones.

H Yssel, J E De Vries, M Koken, W Van Blitterswijk, H Spits.   

Abstract

A serum-free lymphocyte culture medium is described in which serum is replaced by bovine serum albumin, transferrin, insulin, ethanolamine and a mixture of saturated and unsaturated fatty acids (linoleic acid, oleic acid and palmitic acid). In this serum-free medium proliferative and cytotoxic responses induced in mixed lymphocyte culture were comparable with those obtained in medium containing serum. Antigen-specific cytotoxic and helper T cells were isolated and could be propagated in serum-free medium without loss of function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086760     DOI: 10.1016/0022-1759(84)90450-2

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  104 in total

1.  Disruption of alpha beta but not of gamma delta T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors.

Authors:  B Blom; M H Heemskerk; M C Verschuren; J J van Dongen; A P Stegmann; A Q Bakker; F Couwenberg; P C Res; H Spits
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

2.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

3.  A family of beta 7 integrins on human mucosal lymphocytes.

Authors:  C M Parker; K L Cepek; G J Russell; S K Shaw; D N Posnett; R Schwarting; M B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

4.  Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.

Authors:  P Amé-Thomas; J Le Priol; H Yssel; G Caron; C Pangault; R Jean; N Martin; T Marafioti; P Gaulard; T Lamy; T Fest; G Semana; K Tarte
Journal:  Leukemia       Date:  2011-10-21       Impact factor: 11.528

5.  Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease.

Authors:  C A S Menezes; A K Sullivan; M T Falta; D G Mack; B M Freed; M O C Rocha; K J Gollob; A P Fontenot; W O Dutra
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

6.  The interleukin-10 inducing effect of transforming growth factor-beta on human naive CD4+ T cells from cord blood is restricted to the TH1 subset.

Authors:  B Kapitein; M M Tiemessen; W M Liu; A G van Ieperen-van Dijk; M O Hoekstra; E van Hoffen; E F Knol
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

7.  Quantitative proteomics reveals GIMAP family proteins 1 and 4 to be differentially regulated during human T helper cell differentiation.

Authors:  Jan-Jonas Filén; Sanna Filén; Robert Moulder; Soile Tuomela; Helena Ahlfors; Anne West; Petri Kouvonen; Suvi Kantola; Mari Björkman; Mikko Katajamaa; Omid Rasool; Tuula A Nyman; Riitta Lahesmaa
Journal:  Mol Cell Proteomics       Date:  2008-08-12       Impact factor: 5.911

8.  Cytotoxic and noncytotoxic mechanisms involved in the in vitro anti-leukaemia effects of T cell clones established from a chronic myelogenous leukaemia patient during treatment in vivo with interferon alpha.

Authors:  G Pawelec; M Reutter; M Owsianowsky; A Rehbein; F W Busch
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

9.  T cell clones from an X-linked hyper-immunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand.

Authors:  P Life; J F Gauchat; V Schnuriger; S Estoppey; G Mazzei; A Durandy; A Fischer; J Y Bonnefoy
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  In vitro synthesis of human IgE is suppressed by human IgG.

Authors:  H Haas; M Schlaak
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.